Canada markets closed

Gain Therapeutics, Inc. (GANX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.2800+0.0300 (+2.40%)
At close: 04:00PM EDT
1.2200 -0.06 (-4.69%)
After hours: 06:17PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 31.46M
Enterprise Value 19.69M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)255.50
Price/Book (mrq)3.64
Enterprise Value/Revenue 138.33
Enterprise Value/EBITDA -1.55

Trading Information

Stock Price History

Beta (5Y Monthly) 0.48
52-Week Change 3-72.10%
S&P500 52-Week Change 323.20%
52 Week High 35.3300
52 Week Low 31.2000
50-Day Moving Average 32.4102
200-Day Moving Average 33.1894

Share Statistics

Avg Vol (3 month) 3222.87k
Avg Vol (10 day) 3747.79k
Shares Outstanding 525.17M
Implied Shares Outstanding 625.17M
Float 816.83M
% Held by Insiders 16.76%
% Held by Institutions 111.07%
Shares Short (Jun 14, 2024) 4500.33k
Short Ratio (Jun 14, 2024) 41.7
Short % of Float (Jun 14, 2024) 42.97%
Short % of Shares Outstanding (Jun 14, 2024) 42.77%
Shares Short (prior month May 15, 2024) 4100.71k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-74.54%
Return on Equity (ttm)-177.83%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.37M
Net Income Avi to Common (ttm)-21.14M
Diluted EPS (ttm)-1.5000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.66M
Total Cash Per Share (mrq)0.7
Total Debt (mrq)889.62k
Total Debt/Equity (mrq)10.29%
Current Ratio (mrq)2.77
Book Value Per Share (mrq)0.48

Cash Flow Statement

Operating Cash Flow (ttm)-18.24M
Levered Free Cash Flow (ttm)-10.24M